Gramenzi A, Andreone P, Loggi E, Foschi F G, Cursaro C, Margotti M, Biselli M, Bernardi M
Dipartimento di Medicina Interna, Cardioangiologia ed Epatologia, Università degli Studi di Bologna, Italy.
J Viral Hepat. 2005 Sep;12(5):525-30. doi: 10.1111/j.1365-2893.2005.00634.x.
The relationship between the balance of helper T-cell type 1 (Th1) or type 2 (Th2) cytokines and the clinical course of hepatitis C virus (HCV) infection is unclear. We evaluated Th1 [interleukin (IL)-2, interferon-gamma (IFN-gamma)] and Th2 cytokine (IL-4, IL-10) and 2,5-oligoadenylate synthetase (OAS, an IFN-induced antiviral protein) production by peripheral blood mononuclear cells from 10 healthy anti-HCV-positive individuals (group A), 10 HCV-RNA-positive with persistently normal alanine aminotransferase (ALT) levels (group B), 10 HCV-RNA-positive with abnormal ALT (group C) and 10 uninfected healthy controls. IL-2 production was significantly increased in group B when compared with all the other groups. No difference was found for IFN-gamma. IL-4 was significantly higher in group C than in both group B (P = 0.0006) and controls (P = 0.004). Compared with controls, IL-10 was significantly decreased in group A (P = 0.013) and B (P = 0.004). The production of 2,5-OAS was significantly higher in group B than in A (P = 0.04) and in C (P = 0.004). Finally, in all HCV-RNA-positive patients, a significant correlation was found between ALT and both IL-2 (r = -0.78; P = 0.0008) and IL-4 (r = 0.75; P = 0.0008).
(i) subjects who cleared HCV showed a cytokine profile similar to controls; (ii) a preferential shift towards a Th1 profile seems associated with a more favourable clinical outcome in chronic hepatitis C; and (iii) a prevalent Th2 profile seems implicated in HCV pathogenesis and severity of liver disease.
辅助性T细胞1型(Th1)或2型(Th2)细胞因子平衡与丙型肝炎病毒(HCV)感染临床病程之间的关系尚不清楚。我们评估了10名健康抗HCV阳性个体(A组)、10名HCV-RNA阳性且丙氨酸转氨酶(ALT)水平持续正常者(B组)、10名HCV-RNA阳性且ALT异常者(C组)以及10名未感染的健康对照者外周血单个核细胞产生的Th1[白细胞介素(IL)-2、干扰素-γ(IFN-γ)]和Th2细胞因子(IL-4、IL-10)以及2,5-寡腺苷酸合成酶(OAS,一种IFN诱导的抗病毒蛋白)。与所有其他组相比,B组的IL-2产生显著增加。IFN-γ未发现差异。C组的IL-4显著高于B组(P = 0.0006)和对照组(P = 0.004)。与对照组相比,A组(P = 0.013)和B组(P = 0.004)的IL-10显著降低。B组的2,5-OAS产生显著高于A组(P = 0.04)和C组(P = 0.004)。最后,在所有HCV-RNA阳性患者中,ALT与IL-2(r = -0.78;P = 0.0008)和IL-4(r = 0.75;P = 0.0008)之间均存在显著相关性。
(i)清除HCV的受试者细胞因子谱与对照组相似;(ii)慢性丙型肝炎中,向Th1谱的优先转变似乎与更有利的临床结局相关;(iii)占优势的Th2谱似乎与HCV发病机制及肝病严重程度有关。